Janssen Pharma Lawsuit Invega Sustenna

Lawsuits against Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson corporation, have been filed across the country for injuries and deaths associated with their Bad Drugs. Some cases have claims related to products being defectively designed, and others have arisen from Janssen’s failure to adequately warn customers of the potential risks of its products.

Janssen Pharmaceuticals has successfully manufactured dozens of medicines, but it has failed to warn its consumers and their family about the severe side effects some of those medicines can cause. 

Bad Drug Sign-up

Tell your story. Enter your information below to be contacted in regards to joining the lawsuit.

The Janssen Pharmaceutical Company is a subsidiary of Johnson & Johnson. Janssen researches and produces medicines to treat various diseases, such as heart diseases, HIV, Alzheimer’s disease, and different types of cancer. With over 30,000 employees, Janssen is headquartered in Beerse, Belgium.

The company was founded in 1953, and in 1961 became a part of Johnson & Johnson. Janssen develops many drugs that help thousands of people. Unfortunately, some of those drugs have caused serious injuries in patients.

These drugs include:
Invega Sustenna, (paliperidone palmitate) is a poorly tested and administered product indicated for the treatment of Schizophrenia in adults. Schizoaffective disorder as monotherapy and as an adjunct to mood stabilizers or antidepressants in adults.
Risperdal, an antipsychotic drug used to treat schizophrenia, bipolar disorder, and other mental illnesses

Numerous lawsuits have been filed nationwide against Janssen and Johnson & Johnson because of these side effects.

Dr. Paul Janssen was born in 1926, the son of a doctor who had established the family business. After getting his medical degree, Dr. Paul Janssen primarily focused on the importance of chemistry in medicine, and in 1953 founded Janssen Pharmaceutica N.V., a research lab based in Belgium.

In 1961, the American corporation Johnson & Johnson purchased the Janssen pharmaceutical company. Since then, the company has researched and developed over 80 medicines to treat diseases in five healthcare areas:

  • Cardiovascular & Metabolism
  • Immunology
  • Infectious Diseases & Vaccines
  • Neuroscience
  • Oncology

In 2003, Dr. Paul Janssen passed away. In his honor, Johnson & Johnson created The Dr. Paul Janssen Award for Biomedical Research. The company continues to research new treatments for complex diseases to help numerous people globally. However, thousands of people have suffered severe injuries from some of the company’s most popular drugs.

Copyright 2022 The Oklahoma Post

Subscribe Oklahoma!